Podcast Episodes
Back to SearchDC EKG Revisits: Charley Hooper Part 3
Joe and Eric continue their discussion with Charley. The conversation explores how drugmakers approach the market and fund new research. They highlig…
2 years, 5 months ago
DC EKG Revisits: Charley Hooper Part 2
Joe and Eric continue their discussion with Charley. The conversation explores how drugmakers approach the market and fund new research. They highlig…
2 years, 6 months ago
DC EKG Revisits: Charley Hooper Part 2
Joe and Eric continue their discussion with Charley. The conversation explores how drugmakers approach the market and fund new research. They highlig…
2 years, 6 months ago
What you need to know about 2024
Joe and Eric drop invaluable deep takes on how the world will shape up in 2024. From healthcare, to to the elections, to policy, problems, and politi…
2 years, 6 months ago
‘Forecast 24:’ DC EKG previews the year ahead
Joe and Eric drop invaluable deep takes on how the world will shape up in 2024. From healthcare, to to the elections, to policy, problems, and politi…
2 years, 6 months ago
AI: DC Policymakers Face a Crossroads
Hosts Joe Grogan and Eric Ueland explore the paths forward for policymakers grappling with the limitless possibilities of AI. They are joined by prol…
2 years, 7 months ago
Will “doom and gloom “ or “trial and error” be Washington’s AI template?
Hosts Joe Grogan and Eric Ueland explore the paths forward for policymakers grappling with the limitless possibilities of AI. They are joined by prol…
2 years, 7 months ago
The guys talk with healthcare policy expert and Marquette University professor Lisa Grabert
Designed to give seniors more options, the Congress designed MA is ways that be working too well. Highly informative discussion about the wonky detai…
2 years, 7 months ago
DC EKG: Medicare Advantage with Lisa Grabert
Designed to give seniors more options, the Congress designed MA is ways that be working too well. Highly informative discussion about the wonky detai…
2 years, 7 months ago
DC EKG Revisits: Charley Hooper Part 1
Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of …
2 years, 7 months ago